Comparative study of the catalytic thermodynamic barriers for two homologous Mn- and Fe-non-heme oxidation catalysts

Schiff Base Complexes with Covalently Anchored Luminophores: Self-Enhanced Electrochemiluminescence Detection of Neomycin

A novel electrochemiluminescence (ECL) amplification strategy was established aiming to overcome the inherent shortcomings of the current oxygen (O₂) coreactant ECL systems. Macrocyclic Schiff base Fe complexes were rationally designed as a novel integrated ECL emitter by iminium linkage between N-(4-aminobutyl)-N-ethylisoluminol (ABEI) and 1,10-phenanthroline-2,9-dicarbaldehyde (PDL) and postmetalation of the macrocyclic Schiff base. Covalently combining luminophore ABEI with a catalytic center endowed the novel ECL emitter with both remarkable redox electrocatalytic properties and significantly enhanced ECL efficiency. The high content of ferrous iron and the dominantly active low-spin Fe state greatly contributed to the inherent catalytic activity for O₂ activation. The rational modification of luminophore optimized the spatial distribution and simultaneously shortened the species transport distance of coreactant radicals generated in situ from dissolved O₂, resulting in significantly self-enhanced ECL efficiency. Neomycin, which posed a growing threat to aquatic biodiversity and environmental safety, as the model antibiotic was successfully detected with a detection limit of 0.21 pM (S/N = 3), clarifying a promising application prospect of this new luminophore-embedded ECL amplification strategy in biological analysis and environmental monitoring.

A mononuclear tantalum catalyst with a peroxocarbonate ligand for olefin epoxidation in compressed CO2

A mononuclear tantalum complex bonded to a peroxocarbonate ligand has been proved to be particularly important in the epoxidation reactions.

Catalytic oxidation of alcohols with novel non-heme N4-tetradentate manganese(ii) complexes

We report the preparation and characterisation of a series of novel non-heme N4-tetradentate Mn(OTf)2 complexes of the type, [(L)MnOTf2], where L = R,R and S,S enantiomers of BPMCN, its 6-methyl and 6-bromo derivatives as well as the novel ligand BMIMCN (BPMCN = N,N'-dimethyl-N,N'-bis(2-pyridylmethyl)-(R,R/S,S)-1,2-diaminocyclohexane, BMIMCN = N,N'-dimethyl-N,N'-bis(1-methyl-2-imidazolemethyl)-(R,R/S,S)-1,2-diaminocyclohexane). Solid state structural analysis of the BMIMCN-ligated Mn-triflate complexes (R,R-C4 and S,S-C4) revealed opposite helicity but identical metal site accessibility. This feature was exploited in the catalytic oxidation of primary and secondary alcohols, with hydrogen peroxide as oxidant and acetic acid as co-catalyst. Complexes R,R-C4 and S,S-C4 displayed the highest activity in benzyl alcohol oxidation, attributed to the electron-donating property of the BMIMCN ligand. Complex S,S-C4, displayed high activity for a variety of primary alcohol substrates, but the reaction suffered from reduced selectivity and side-reactions due to the presence of acetic acid. In contrast, secondary alcohol substrates could be oxidised to the corresponding ketone products in excellent isolated yields under mild reaction conditions and short reaction times.

Hybrid metal complexes with opposed biological modes of action – promising selective drug candidates

The oxidative stress is considered to be involved in the pathogenesis of many diseases. The antioxidative defense system in the living organism regulates the toxic impact of ROS and there is strong evidence that the antioxidants prevent some pathologies including cancer. The specific chemical properties of metal-based drugs impart innovative pharmacological profiles to this type of therapeutic agents, most likely in relation to novel biomolecular mechanisms. This review will focus on a novel approach to design polyfunctional metal-based physiollogically active compounds with opposed modes of action – prooxidant metal center and antioxidant 2,6-dialkylphenol group. The synthesis and anti/prooxidant activity and cytotoxicity studies of novel organometallic/coordination compounds (ferrocenes, complexes with di-(2-picolyl)amine ligand, porphyrins, pyridines, thiols, carboxylates) based on either biogenic metals (Fe, Mn, Co, Cu, Zn, Ni) or exogenic metals (Sn, Au, Rh) are presented and discussed. The results allow us to conclude that combining in one molecule a redox active metal center and cytoprotective functional organic moiety with antioxidative function is a promising way to rational metallodrug design in modern medicinal chemistry.